(Q35541984)

8 August 2017

1 reference

title

Autoantibodies in the diagnosis and management of liver disease (English)

1 reference

8 August 2017

Autoantibodies in the Diagnosis and Management of Liver Disease (English)

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

13 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

13 March 2024

author name string

Albert J. Czaja

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506390

13 March 2024

Gary L. Norman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506390

13 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14506390

13 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

http://journals.lww.com/00004836-200310000-00011

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Journal of Clinical Gastroenterology

13 March 2024

published in

1 reference

8 August 2017

37

1 reference

8 August 2017

4

1 reference

8 August 2017

315-329

1 reference

Understanding the pathogenesis of autoimmune hepatitis

8 August 2017

1

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

13 March 2024

Journal of Immunology

2

161

3527

Doherty

1998

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

13 March 2024

Autoantibodies

3

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Autoantibodies in liver disease

13 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

The Journal of Rheumatology

13 March 2024

5

20

211

Senecal

1993

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

The significance of natural autoantibodies

13 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

13 March 2024

Journal of Immunology

7

158

968

Diaw

1997

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Positive selection of natural autoreactive B cells

13 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Behavior and significance of autoantibodies in type 1 autoimmune hepatitis

13 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Diagnosis and treatment of autoimmune hepatitis

13 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis

13 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Genetic predispositions for the immunological features of chronic active hepatitis

13 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Immunologic features and HLA associations in chronic viral hepatitis

13 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis

13 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis

13 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Immune phenotype of chronic liver disease.

13 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

13 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis

13 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Range of antinuclear antibodies in "healthy" individuals

13 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance

13 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Cytoskeleton Antibodies in Chronic Active Hepatitis, Primary Biliary Cirrhosis, and Alcoholic Liver Disease

13 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis

13 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.

13 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase

13 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera.

13 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

13 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of America

13 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies

13 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection

13 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Patients with type II autoimmune hepatitis express functionally intact cytochrome P-450 db1 that is inhibited by LKM-1 autoantibodies in vitro but not in vivo

13 March 2024

35

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis

13 March 2024

36

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis

13 March 2024

37

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21

13 March 2024

39

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Positional cloning of the APECED gene

13 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1

13 March 2024

41

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

13 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis

13 March 2024

43

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

13 March 2024

45

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis.

13 March 2024

46

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis

13 March 2024

47

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression

13 March 2024

48

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Antimitochondrial antibodies in primary biliary cirrhosis. A clue to its etiopathogenesis?

13 March 2024

49

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies

13 March 2024

50

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Positive markers in AMA-negative PBC

13 March 2024

52

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens

13 March 2024

53

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

13 March 2024

56

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.

13 March 2024

57

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.

13 March 2024

58

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis

13 March 2024

60

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins

13 March 2024

61

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

"Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines

13 March 2024

62

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure

13 March 2024

64

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Celiac disease in autoimmune cholestatic liver disorders

13 March 2024

65

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Celiac disease-associated autoimmune cholangitis

13 March 2024

66

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin

13 March 2024

67

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences

13 March 2024

68

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis

13 March 2024

69

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Primary sclerosing cholangitis and celiac disease. A novel association

13 March 2024

70

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Endomysial antibody in the diagnosis and management of coeliac disease

13 March 2024

72

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease

13 March 2024

73

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

IgA antiendomysial antibodies on the umbilical cord in diagnosing celiac disease. Sensitivity, specificity, and comparative evaluation with the traditional kit

13 March 2024

74

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Identification of tissue transglutaminase as the autoantigen of celiac disease

13 March 2024

75

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy

13 March 2024

76

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Antibody reactivity against human and guinea pig tissue transglutaminase in children with celiac disease

13 March 2024

77

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Anti-transglutaminase IgA ELISA: clinical potential and drawbacks in celiac disease diagnosis.

13 March 2024

78

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits

13 March 2024

79

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease

13 March 2024

80

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Autoantibodies to tissue transglutaminase as predictors of celiac disease

13 March 2024

81

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

IgA antibodies against endomysium and transglutaminase: A comparison of methods

13 March 2024

82

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Endomysial and tissue transglutaminase antibodies in coeliac sera: a comparison not influenced by previous serological testing

13 March 2024

83

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Sensitivity of anti-endomysial antibody in detecting celiac disease

13 March 2024

84

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study

13 March 2024

85

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Anti-tissue transglutaminase antibody as the first line screening for celiac disease: good-bye antigliadin tests?

13 March 2024

86

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Histones: genetic diversity and tissue-specific gene expression

13 March 2024

87

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Frequency and significance of antibodies to histones in autoimmune hepatitis.

13 March 2024

88

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis.

13 March 2024

89

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis

13 March 2024

90

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis

13 March 2024

91

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

The immunologic diagnosis of chronic active "autoimmune" hepatitis: distinction from systemic lupus erythematosus

13 March 2024

92

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis

13 March 2024

94

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Anti-actin antibodies: a new test for an old problem

13 March 2024

95

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Heat serum inactivation as a mandatory procedure for antiactin antibody detection in cell culture

13 March 2024

96

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis

13 March 2024

97

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics

13 March 2024

98

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen

13 March 2024

99

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis

13 March 2024

100

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis

13 March 2024

101

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis

13 March 2024

102

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis

13 March 2024

103

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease

13 March 2024

104

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders

13 March 2024

106

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis

13 March 2024

107

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

The asialoglycoprotein receptor as target structure in autoimmune liver diseases

13 March 2024

108

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis

13 March 2024

109

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis

13 March 2024

110

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis

13 March 2024

111

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1

13 March 2024

112

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Argininosuccinate lyase: a new autoantigen in liver disease

13 March 2024

113

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

New autoantibodies and autoantigens in autoimmune hepatitis

13 March 2024

114

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2

13 March 2024

115

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis

13 March 2024

116

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis

13 March 2024

117

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Nuclear envelope protein autoantibodies in primary biliary cirrhosis

13 March 2024

119

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore

13 March 2024

120

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis

13 March 2024

121

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders

13 March 2024

122

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis

13 March 2024

123

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease

13 March 2024

124

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D.

13 March 2024

125

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus

13 March 2024

126

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus

13 March 2024

127

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

The role of nucleosomes in lupus

13 March 2024

128

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria

13 March 2024

129

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Frequency and significance of antibodies to chromatin in autoimmune hepatitis type I

13 March 2024

130

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Anti-Saccharomyces cerevisiae antibodies in autoimmune liver disease

13 March 2024

133

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure

13 March 2024

134

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

The nature and prognostic implications of autoimmune hepatitis with an acute presentation

13 March 2024

135

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

13 March 2024

136

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

The nature and prognosis of severe cryptogenic chronic active hepatitis.

13 March 2024

137

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

The variant forms of autoimmune hepatitis

13 March 2024

138

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Recurrent autoimmune hepatitis after orthotopic liver transplantation

13 March 2024

139

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

De-novo autoimmune hepatitis after liver transplantation

13 March 2024

140

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance

13 March 2024

141

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

Response to steroids in de novo autoimmune hepatitis after liver transplantation

13 March 2024

142

1 reference

https://api.crossref.org/works/10.1097/00004836-200310000-00011

13 March 2024

Identifiers

1 reference

release_vjmupd7npze6zfdx7rggh2yhxi

8 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vjmupd7npze6zfdx7rggh2yhxi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference